Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Why Bausch Health Companies (TSX:BHC) Is up Over 30% in 2021

Stock MarketsSep 22, 2021 08:16
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
Why Bausch Health Companies (TSX:BHC) Is up Over 30% in 2021

Bausch Health Companies (TSX:BHC)(NYSE:BHC) continues to climb in the last year, up about 30% year to date as of writing and 54% in the last year. Health companies like Bausch stock have been doing well with the end of the pandemic hopefully near. And as of writing, shares of the company exploded 7% overnight. So, let’s dig into why Bausch stock specifically continues to climb.

What happened? Bausch stock continues to see positive momentum thanks to a strong quarter that included updated 2021 guidance. Earnings beat analyst expectations, reporting increased year-over-year revenue of 26%, repaying debt of US$500 million, with plans to further pay down another US$350 million in debt. Bausch stock also announced earnings per share (EPS) of $1.66, almost double the $0.92 made in 2020 and far ahead of analyst expectations. But furthermore, the company also announced some strong notes for the future. Its Solta Medical business should soon announce its initial public offering.

However, the company also revised its annual guidance, bringing down expected revenue range to between $8.4 and $8.6 billion from $8.6 and $8.8 billion. This came down to a few problems that management believes are merely one-offs. Plus, the sale of its Amoun Pharmaceutical Company S.A.E for US$740 million will certainly help in the near future.

But investors should also be aware of a recent drop in Bausch stock. This came from a lawsuit where Bausch agreed to pay US$300 million to settle an antitrust lawsuit. The company was accused of “illegally maintaining a monopoly on the diabetes drug Glumetza.” This led to a price hike of 800% back in 2015.

So what? The company has changed since 2015 — even changing its name from Valeant Pharmaceuticals (NYSE:BHC) — but the sting is still there. And this could lead to further losses and bad press leading to poorer financial outcomes. The deal, if approved, has already been dubbed the second-largest, or even, indeed, the largest, recovery ever for a case such as this. Shares of Bausch stock dropped when the announcement was made, falling for five consecutive days straight.

And then suddenly, it wasn’t.

Shares of Bausch stock suddenly exploded overnight after Monday’s trading. Bausch stocked climbed about 7% after an analyst conducted a sum-of-the-parts analysis. The analyst believes the stock is worth at minimum $40 per share. That is still below where it trades at writing at $36 per share and far away from the $33 trading on Monday.

Now what? If you’re looking to invest in Bausch stock, I would look at the company’s fundamentals. It has a solid pipeline in the future and remains weighed down by short-term financial fallbacks. The sale of Amoun and the Solta IPO will be strong for the company’s business moving forward. Furthermore, it offers a valuable EV/EBITDA of 10.71 as of writing and price-to-sales ratio of 1.56.

Before the fallout of 2015, shares of the company exploded. And with new medications on the rise, that company is still far away from those numbers. It might be a solid time for investors to jump on this stock on the back of positive reports, especially now that the 2015 settlement is complete. Bausch stock may finally be able to move on, so investors may want to get on board while they can.

The post Why Bausch Health Companies (TSX:BHC) Is up Over 30% in 2021 appeared first on The Motley Fool Canada.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Bausch Health Companies.

This Article Was First Published on The Motley Fool

Why Bausch Health Companies (TSX:BHC) Is up Over 30% in 2021
 

Related Articles

2 Insanely Cheap TSX Stocks That Pay Great Dividends
2 Insanely Cheap TSX Stocks That Pay Great Dividends By The Motley Fool - Dec 07, 2021

The recent TSX stock market decline is a true gift for contrarian investors. Frankly, there is a lot to worry about these days (the Omicron variant, the U.S. Federal Reserve...

Playbook for the Omicron Scare 2021: Stay Invested!
Playbook for the Omicron Scare 2021: Stay Invested! By The Motley Fool - Dec 07, 2021

The impact of COVID-19 on the stock market in 2020 was severe. Fortunately, the TSX bounced back remarkably and even had a bull run for most of 2021. Now, a new COVID strain...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email